- Home
- ADVB vs ACXP Comparison
ADVB vs ACXP Comparison
Compare ADVB & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVB
- ACXP
- Stock Information
- Founded
- ADVB 2014
- ACXP 2017
- Country
- ADVB United States
- ACXP United States
- Employees
- ADVB N/A
- ACXP N/A
- Industry
- ADVB Medical Specialities
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- ADVB Health Care
- ACXP Health Care
- Exchange
- ADVB Nasdaq
- ACXP Nasdaq
- Market Cap
- ADVB 9.1M
- ACXP 9.1M
- IPO Year
- ADVB 2025
- ACXP 2021
- Fundamental
- Price
- ADVB $0.42
- ACXP $4.09
- Analyst Decision
- ADVB
- ACXP Strong Buy
- Analyst Count
- ADVB 0
- ACXP 3
- Target Price
- ADVB N/A
- ACXP $143.67
- AVG Volume (30 Days)
- ADVB 371.2K
- ACXP 85.5K
- Earning Date
- ADVB 11-03-2025
- ACXP 08-12-2025
- Dividend Yield
- ADVB N/A
- ACXP N/A
- EPS Growth
- ADVB N/A
- ACXP N/A
- EPS
- ADVB N/A
- ACXP N/A
- Revenue
- ADVB N/A
- ACXP N/A
- Revenue This Year
- ADVB N/A
- ACXP N/A
- Revenue Next Year
- ADVB N/A
- ACXP N/A
- P/E Ratio
- ADVB N/A
- ACXP N/A
- Revenue Growth
- ADVB N/A
- ACXP N/A
- 52 Week Low
- ADVB $0.34
- ACXP $3.80
- 52 Week High
- ADVB $4.10
- ACXP $44.00
- Technical
- Relative Strength Index (RSI)
- ADVB N/A
- ACXP 33.75
- Support Level
- ADVB N/A
- ACXP $3.83
- Resistance Level
- ADVB N/A
- ACXP $7.15
- Average True Range (ATR)
- ADVB 0.00
- ACXP 0.60
- MACD
- ADVB 0.00
- ACXP 0.05
- Stochastic Oscillator
- ADVB 0.00
- ACXP 7.83
About ADVB Advanced Biomed Inc. Common Stock
Advanced Biomed Inc operates through its subsidiaries that are responsible for the main operation and the design and development of the company's primary technologies and products. It has been focusing on the integration of multiple interdisciplinary technologies and established its microfluidic technology platform. Utilizing the physical and molecular biological characteristics of tumor cells, the company has developed various advanced and original research through the joint application of semiconductor technology and biotechnology. devices, A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.